Investigating biomarkers for type 2 diabetes prevention
Phosphatidylcholine and cholesterol ester biomarkers of type 2 diabetes and preventive treatment effects
This study is looking for certain markers in your body that can help predict if you might develop type 2 diabetes, so we can find the best ways to prevent it, like lifestyle changes or medications, and we’d love for patients to help by sharing samples and information.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11098641 on NIH RePORTER |
What this research studies
This research focuses on identifying specific biomarkers related to phosphatidylcholine and cholesterol esters that can help predict the risk of developing type 2 diabetes. By analyzing these biomarkers, the study aims to determine which preventive treatments, such as lifestyle changes or medications, are most effective for individuals at high risk. The approach combines laboratory research with clinical studies to enhance understanding of diabetes prevention. Patients may be involved in providing samples and data to help validate these biomarkers.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are at high risk for developing type 2 diabetes.
Not a fit: Patients who are not at risk for type 2 diabetes or those who already have the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective prevention strategies for type 2 diabetes.
How similar studies have performed: Previous research has shown promise in using metabolite biomarkers for predicting diabetes risk, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Chen, Zsu-Zsu — Beth Israel Deaconess Medical Center
- Study coordinator: Chen, Zsu-Zsu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.